You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Antibiotic adjuvant therapy for pulmonary infection in cystic fibrosis
|
|---|---|
| Published in |
Cochrane database of systematic reviews, June 2013
|
| DOI | 10.1002/14651858.cd008037.pub3 |
| Pubmed ID | |
| Authors |
Matthew N Hurley, Douglas L Forrester, Alan R Smyth |
| Abstract |
Cystic fibrosis is a multi-system disease characterised by the production of thick secretions causing recurrent pulmonary infection, often with unusual bacteria. This leads to lung destruction and eventually death through respiratory failure. There are no antibiotics in development that exert a new mode of action and many of the current antibiotics are ineffective in eradicating the bacteria once chronic infection is established. Antibiotic adjuvants - therapies that act by rendering the organism more susceptible to attack by antibiotics or the host immune system, by rendering it less virulent or killing it by other means, are urgently needed. |
X Demographics
The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 1 | 17% |
| Unknown | 5 | 83% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 6 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 156 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Australia | 1 | <1% |
| Unknown | 155 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 24 | 15% |
| Student > Master | 23 | 15% |
| Student > Bachelor | 20 | 13% |
| Researcher | 13 | 8% |
| Student > Postgraduate | 8 | 5% |
| Other | 25 | 16% |
| Unknown | 43 | 28% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 49 | 31% |
| Nursing and Health Professions | 17 | 11% |
| Psychology | 7 | 4% |
| Pharmacology, Toxicology and Pharmaceutical Science | 6 | 4% |
| Social Sciences | 5 | 3% |
| Other | 25 | 16% |
| Unknown | 47 | 30% |
Attention Score in Context
This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 June 2013.
All research outputs
#7,236,093
of 25,457,858 outputs
Outputs from Cochrane database of systematic reviews
#8,304
of 11,842 outputs
Outputs of similar age
#58,530
of 210,184 outputs
Outputs of similar age from Cochrane database of systematic reviews
#203
of 295 outputs
Altmetric has tracked 25,457,858 research outputs across all sources so far. This one has received more attention than most of these and is in the 71st percentile.
So far Altmetric has tracked 11,842 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 38.9. This one is in the 26th percentile – i.e., 26% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 210,184 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 71% of its contemporaries.
We're also able to compare this research output to 295 others from the same source and published within six weeks on either side of this one. This one is in the 30th percentile – i.e., 30% of its contemporaries scored the same or lower than it.